Skip to content
Effectuez une recherche pour en savoir plus sur les produits et solutions InterSystems, les offres d'emploi, etc.

Conducting Decentralized Clinical Studies

With Smart Consumer Technology, InterSystems IRIS for Health, and HL7 FHIR

father holding young son while on a telehealth call with the peditrician

Getting enough people to enroll and participate to the end of a clinical study is a major challenge. Most studies fail to enroll enough subjects to even begin. And if you can’t enroll enough people, you certainly can’t gather enough data to ensure statistically sound results.
Today, researchers are addressing these challenges by decentralizing studies – offering components of the study to the patient at home, instead of requiring participants to visit study sites. As of 2021, 48%-95% of research sites report using at least one form of decentralized technology.1

InterSystems IRIS for Health™ data platform supports decentralized and hybrid study models, enabling researchers to gather data from study participants, connected remote, wearable, or implanted medical devices, and electronic health records, health information exchanges, and other sources. Combined and transformed by InterSystems IRIS for Health into a single consistent format, such as HL7® FHIR® (FHIR), this data becomes the foundation for analysis and a comprehensive perspective on patient health and treatment effectiveness. Researchers in pharma, life sciences, and MedTech organizations can create a virtuous circle of feedback that drives continuous improvements in research, care, and outcomes.

Create a virtuous circle where device and other real-world data, aggregated, transformed, and delivered by InterSystems, helps drive continuous improvement in research, analytics, patient care and outcomes - Diagram
Create a virtuous circle where device and other real-world data, aggregated, transformed, and delivered by InterSystems, helps drive continuous improvement in research, analytics, patient care and outcomes.

Customer Use Case: Medical Device Maker

A major medical device maker conducted a decentralized study supported by InterSystems IRIS for Health data platform to gain a full, multi-dimensional view of therapy effectiveness. InterSystems IRIS for Health aggregated and transformed device, performance, time series, patient reported outcomes, and electronic health record data into FHIR format, and prepared it for access through the SQL already familiar to data scientists. Using InterSystems IRIS for Health, the data scientists gained the context they needed around the raw device data to answer critical questions using predictive and operational analytics. The platform and smart consumer technology enabled this customer to:

  • Conduct a decentralized clinical study efficiently to validate and improve device performance
  • Illuminate factors influencing variations in disease course among patients
  • Provide guidance to clinicians on personalizing patient treatment
  • Increase the value of the patient monitoring program

InterSystems IRIS for Health

InterSystems IRIS for Health can make studies more diverse and easier to participate in by gathering data from the subject at home, as well as devices and the hospital or clinic. By aggregating and normalizing diverse data types for analytics, machine learning, and AI systems, it helps researchers answer questions about treatment performance and function, track patient progress, and identify study issues before they become problems.


1 - McKinsey and Company, “No place like home? Stepping up the decentralization of clinical trials.”
https://www.mckinsey.com/industries/life-sciences/our-insights/no-place-like-home-stepping-up-the-decentralization-of-clinical-trials

Autres Ressources Que vous Pourriez Apprécier

17 Nov 2026
TabbFORUM’s Market Structure Wave
Over the past 12 to 18 months, the conversation in capital markets has shifted from “what can AI do?” to “where can AI deliver measurable value safely and repeatedly?” Most tier 1 and tier 2 institutions have moved beyond isolated proofs of concept. The challenge now is scaling AI across the enterprise, and that depends on the data behind it.
17 Nov 2026
The Era of Execution at Scale
This TabbFORUM report explores how AI is moving from cool novelty to core infrastructure, what’s working in production today, and where the next wave of adoption will determine lasting competitive advantage.
17 Nov 2026
Safely Connecting Agents to Enterprise Execution
A Technical Architecture Perspective for CTOs, Chief Architects, and Engineering Leaders
26 Oct 2026
Partnership
When SHD Group took a fresh look at its long-established technology landscape, nothing was taken for granted.
21 Oct 2026
Présentation de la solution
Découvrez comment l’intelligence décisionnelle permet d’optimiser les stocks, d’anticiper les perturbations et d’améliorer les marges, sans remplacer les systèmes existants.
09 Oct 2026
AMIA Webinar
Healthcare organizations are investing rapidly in AI, but many efforts remain fragmented across applications, data pipelines, and workflows. This makes it difficult to govern AI consistently, evaluate results in context, and build the trusted foundation needed for enterprise adoption.
25 Sep 2026
White Paper
Independent Research Study of InterSystems IntelliCare at EMC Healthcare
25 Sep 2026
Industry Insights
The future of healthcare will be shaped by whether AI fits naturally into clinical work, whether clinicians trust it, whether governance makes adoption safer, and whether outcomes can be measured in real healthcare environments.
21 Sep 2026
AI in Healthcare
Dr. Emeline Ramos speaks with MIT researcher Dr. Angelica Marotta about how artificial intelligence is beginning to transform healthcare delivery—not by replacing clinicians, but by helping them spend less time at the computer and more time with patients. Drawing on research from a hospital AI deployment, the conversation explores how generative AI can reduce documentation burden, improve communication, increase eye contact, and support better clinical workflows while reinforcing the importance of trust, risk management, and keeping humans in the loop. Watch the video to hear practical insights for healthcare leaders, clinicians, and technology teams navigating the next phase of AI adoption.
02 Sep 2026
Solution Summary
Reduce Canceled Procedures Due to Inventory Shortages

Passez à l'étape suivante

Nous serions ravis d'échanger avec vous. Remplissez les champs suivants et nous vous recontacterons.
*Champs obligatoires
*Champs obligatoires
*Champs obligatoires
*Champs obligatoires
** En cochant cette case, vous consentez à recevoir des actualités, des mises à jour et toute autre information à objectif marketing liés aux produits et événements actuels et futurs d'InterSystems. En outre, vous consentez à ce que vos coordonnées professionnelles soient saisies dans notre solution CRM hébergée aux États-Unis, mais conservées conformément aux lois applicables en matière de protection des données.